DMTR.L Regulatory News (DMTR)

 11 June 2018

DeepMatter Group Plc

("DeepMatter" or the "Company")

Directorate Changes

DeepMatter Group Plc (AIM: DMTR), the AIM company focusing on digitizing chemistry, announces that Mark Warne, currently Executive Chairman of the Company, has been appointed as its Chief Executive Officer with effect from 2 July 2018.

Mark, who joined DeepMatter as a Non-Executive Director in September 2015, ‎was appointed Executive Chairman in April 2017. James-Ede Golightly, Non-Executive Director of the Company, will become Non-Executive Chairman with effect from 2 July 2018 on an interim basis whilst a search for a new Non-Executive Chairman is undertaken.

Mark Warne is widely recognised in the UK and International life sciences sector, having joined IP Group Plc, a leading intellectual property commercialisation company, in 2008 where he led the Healthcare team. He managed a portfolio of £330m of net assets in 2016/2017 and represents IP Group on the boards of both listed and private companies. In 2018, concurrent with the integration of Touchstone Innovations into IP Group, Mark became a Partner in the Life Sciences division. He joined IP Group from pre-clinical drug discovery CRO, Exelgen, where he was Managing Director. Mark spent eight years at Exelgen (formerly Tripos Discovery Research) where he also held positions in licensing and strategic affairs, project management and research. He has a PhD in Computational Chemistry, an MSc in Colloid Science and a BSc in Chemistry, all from the University of Bristol. Mark is a Chartered Chemist and member of the Royal Society of Chemistry. Mark will be leaving IP Group on 29 June 2018, but will continue as IP Group's appointed non-executive director on the boards of Genomics plc and hVIVO plc.

Commenting on the announcement, Mark Warne said:

"The increasing level of industry interest that DeepMatter is receiving makes it a particularly exciting time to be taking on the role of CEO. DeepMatter's core expertise in big data collection, structuring and analysis is applicable to many sectors, particularly the now rapidly growing Scientific Data and Internet of Lab Things market. With a good pipeline of opportunities, I feel confident that DeepMatter can create significant shareholder value."

For further information: